The mechanism of Jujuboside A in treating DKD is similar to Diosgenin targeting CaMKK2 in the aforementioned experiments (ZhongLuo et al. 2022), demonstrating the importance of autophagy, mitochondrial autophagy, and ER homeostasis in DKD treatment. The gene discussed is CAMKK2; the disease is diabetic kidney disease.